BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 141241)

  • 1. [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].
    Jarisch R; Sandor I
    Arch Dermatol Res (1975); 1977 Apr; 258(2):151-9. PubMed ID: 141241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)].
    Jarisch R; Sandor I; Cerni C
    Arch Dermatol Res; 1979 May; 265(1):15-22. PubMed ID: 224827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex: treatment today.
    Nuss DD; Aeling JL
    Cutis; 1977 Aug; 20(2):237-41. PubMed ID: 891246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of recurrent herpes simplex using levamisole].
    Luderschmidt C; Wolff HH
    Hautarzt; 1979 Jan; 30(1):21-4. PubMed ID: 422356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG immunoprophylaxis of recurrent herpes progenitalis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1410-5. PubMed ID: 183605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
    Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
    Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ
    Wien Klin Wochenschr; 1977 Nov; 89(22):741-8. PubMed ID: 201107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination].
    Hippmann G; Wekkeli M; Rosenkranz AR; Jarisch R; Götz M
    Wien Klin Wochenschr; 1992; 104(7):200-4. PubMed ID: 1523844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of recurrent herpes simplex and recurring stomatitis with levamisol].
    Luderschmidt C
    Z Hautkr; 1979 May; 54(10):421-3. PubMed ID: 473837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind cross-over study of levamisole as immunoprophylaxis for recurrent herpes progenitalis.
    Bierman SM
    Cutis; 1978 Mar; 21(3):352-4. PubMed ID: 343999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole.
    Rabson AR; Whiting DA; Anderson R; Glover A; Koornhof HJ
    J Infect Dis; 1977 Jan; 135(1):113-6. PubMed ID: 833443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole in patients with recurrent herpes infection.
    Jose DG; Minty CC
    Med J Aust; 1980 Oct; 2(7):390-4. PubMed ID: 7005629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cell-mediated immune response in patients with recurrent herpes simplex treated with decaris].
    Olszewska Z; Dabkowski R; Kubasiewicz M
    Przegl Dermatol; 1988; 75(1):17-23. PubMed ID: 3260388
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated neonatal herpes simplex infection treated with levamisole. Report of a case.
    Constantopoulos A; Lagos P; Benetos S; Matsaniotis N
    Dermatologica; 1980; 160(2):121-4. PubMed ID: 7351276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BCG therapy of recurrent herpes simplex type 1 and 2 (HSV-1 and 2)].
    Fanta D; Dostal V; Reiss-Gutfreund R
    Z Hautkr; 1977 Nov; 52(21):1099-104. PubMed ID: 930227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurring viral dermatoses. Therapeutic possibilities].
    Fanta D; Söltz-Szöts J
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):23-4. PubMed ID: 6154232
    [No Abstract]   [Full Text] [Related]  

  • 19. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).
    Anderson FD; Ushijima RN; Larson CL
    Obstet Gynecol; 1974 Jun; 43(6):797-805. PubMed ID: 4364209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.